NCT04180904Completed
Diet Interventions in Psoriatic Arthritis
Source: ClinicalTrials.gov · Last updated 29 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 92 (actual)
- First submitted
- 14 Nov 2019
- Start date
- 11 Mar 2021
- Primary completion date
- 25 Nov 2024
- Lead sponsor
- University of Pennsylvania
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT04180904
What you commit to
- Study type: Interventional
- Participants enrolled: 92
- From 11 Mar 2021 to the primary completion date, 25 Nov 2024
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of systemic corticosteroids
Other illness
- All persons who would be placed at an increased risk including any medical condition that will impair the ability of the person to participate in a nutritional intervention study (e.g. insulin dependent diabetes, use of coumadin, advanced malignancy, inflammatory bowel disease, dementia)
- History of food allergy to any of the components of olive oil or nuts
Age
- Known pregnancy (pregnancy testing will be performed for women of childbearing age; weight changes will not accurately reflect the changes we would anticipate in pregnant patients and weight loss may be detrimental to maternal and/or fetal outcomes).
Other
- Inability to provide informed consent
- Plan to change systemic treatment for psoriasis or PsA in the next 4-8 weeks
- Inability to read and write in English
- Unwillingness to change dietary habits
- Participation in another physical activity study and/or diet trial
Who the study is looking for
- Age 18-80
- Required Rheumatologist-confirmed diagnosis of PsA fulfilling Classification of Psoriatic Arthritis Criteria (CASPAR)
- Willing to alter diet and participate for 24 weeks
- Able to attend follow-up visits
- Body mass index (BMI) \> 25 and \<40
- No history of eating disorders such as anorexia or bulimia
- Disease Activity in Psoriatic Arthritis Assessment (DAPSA) \> 10
- Stable treatment for PsA for ≥3 months prior to enrollment (patients may be on any disease modifying anti-rheumatic drugs (DMARDs) or they can be free of systemic medications
- Owns and uses an iPhone or Android smart phone, or is willing to use a device provided by the study team
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Women's College Hospital, University of Toronto Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.